Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease

(2018) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis

(2017) Guangqin Xiao et al.   HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus

(2016) Kenneth Cusi et al.   ANNALS OF INTERNAL MEDICINE

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

(2016) Salvatore Petta et al.   HEPATOLOGY

Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis

(2016) Naoyuki Fujimori et al.   HEPATOLOGY RESEARCH

Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B

(2015) Y. Li et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

(2015) Salvatore Petta et al.   HEPATOLOGY

Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis

(2015) Mi Na Kim et al.   HEPATOLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

(2015) Stuart McPherson et al.   JOURNAL OF HEPATOLOGY

Association Between Anthropometric Parameters and Measurements of Liver Stiffness by Transient Elastography

(2012) Grace Lai–Hung Wong et al.   Clinical Gastroenterology and Hepatology

Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation

(2012) Seung Up Kim et al.   PLoS One

Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research

(2012) David Kleiner et al.   SEMINARS IN LIVER DISEASE

Obesity and Metabolic Syndrome in Korea

(2012) Sang Woo Oh   Diabetes & Metabolism Journal

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

(2011) S. Petta et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C

(2011) Claudia Verveer et al.   LIVER INTERNATIONAL

Mild-to-Moderate Elevation of Alanine Aminotransferase Increases Liver Stiffness Measurement by Transient Elastography in Patients With Chronic Hepatitis B

(2010) James Fung et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)

(2010) Kyu Sik Jung et al.   HEPATOLOGY

Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B

(2010) Patrick Marcellin et al.   LIVER INTERNATIONAL

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY